I continue to work to expand treatment and prevention efforts instead of enacting stricter criminal penalties.
He will continue to expand treatment and prevention efforts for opioid addiction rather than rely on stricter criminal penalties.
Occurrences
Evidence
Neal lauded committee passage of the Medicare and Opioid Safe Treatment (MOST) Act of 2018. The release says the bill focused on providing access to treatment for Medicare beneficiaries suffering from opioid use disorder, expanding access to opioid treatment providers and grant support for medication-assisted treatment training.
Neal said Congress should identify solutions to address opioid abuse and dependence in Medicare, noting that Medicare did not cover outpatient treatment programs or methadone and that Congress could help by eliminating federal barriers to treatment and access, and supporting families and law enforcement.
Neal said he was proud of the committee’s work on the bipartisan SUPPORT Act, which made progress in combating the opioid crisis and included policies like adding Opioid Treatment Programs as Medicare providers.
Neal announced a federal HHS opioid-impacted family support grant for Holyoke Community College and said he remained committed to using committee jurisdiction to assist those who struggle with opioid abuse and to combat the epidemic with resources.
Neal helped introduce bipartisan legislation aimed at preventing prescription drug and heroin overdoses, including naloxone access and treatment-related measures.
Assessments
Neal materially advanced treatment-focused opioid policy while serving in federal office, including committee passage of his Medicare opioid treatment legislation and work on bipartisan SUPPORT Act provisions that expanded Medicare access to opioid treatment programs and medication-assisted treatment support. Additional grant and overdose-prevention efforts reinforce that he pursued treatment and prevention resources rather than primarily stricter criminal penalties. The evidence is somewhat historical rather than current to 2026, but the promised policy direction was concretely advanced during his House tenure.
The evidence shows Neal consistently backed opioid policy centered on treatment and prevention rather than harsher criminal penalties, including hearings, bill work, committee action on the MOST Act, support for the SUPPORT Act, and promotion of grants and Medicare coverage changes for treatment. But the claim is framed as continuing to expand those efforts, and the record here shows advocacy and partial policy advancement rather than clear proof that he fully delivered a broad expansion commitment on his own. Because there is concrete legislative and oversight effort with some real policy progress, but not enough evidence of full fulfillment of the promise, partial is the best fit.